Research Topics
| Daniel A MontiSummaryAffiliation: Thomas Jefferson University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Changes in cerebral blood flow and anxiety associated with an 8-week mindfulness programme in women with breast cancerDaniel A Monti
Jefferson Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
Stress Health 28:397-407. 2012..The results demonstrate that the MBAT programme was associated with significant changes in CBF, which correlated with decreased anxiety over an 8-week period...
Short term correlates of the Neuro Emotional Technique for cancer-related traumatic stress symptoms: a pilot case seriesDaniel A Monti
Department of Psychiatry and Human Behavior, Thomas Jefferson University and Hospital, 111 S 11th Street, Philadelphia, PA 19107, USA
J Cancer Surviv 1:161-6. 2007..Treatment options for the hallmark symptoms of traumatic stress--unpleasant, intrusive thoughts and avoidant behaviors--have not been well investigated for the cancer survivorship population...
Potential role of mind-body therapies in cancer survivorshipDaniel A Monti
Myrna Brind Center of Integrative Medicine, Thomas Jefferson University and Hospital, Philadelphia, Pennsylvania 19107, USA
Cancer 112:2607-16. 2008..A theoretical foundation by which such therapies provide benefit is presented, with particular emphasis on self-regulation...
Managing cancer pain with nonpharmacologic and complementary therapiesLynette A Menefee Pujol
Jefferson Pain Center, Department of Anesthesiology, Jefferson Medical College, 834 Chestnut St, Philadelphia, PA 19107 5127, USA
J Am Osteopath Assoc 107:ES15-21. 2007..This review updates an article published in November 2005. An anecdotal case study has been added to illustrate incorporation of nonpharmacologic and complementary therapies in the treatment of a patient with cancer-related pain...
Complementary medicine in chronic cancer careDaniel A Monti
Department of Psychiatry and Human Behavior, Jefferson Medical College, Philadelphia, PA 19107, USA
Semin Oncol 32:225-31. 2005....
A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancerDaniel A Monti
Thomas Jefferson University, Philadelphia, PA 19107, USA
Psychooncology 15:363-73. 2006..This investigation of MBAT provides initial encouraging data that support a possible future role for the intervention as a psychosocial treatment option for cancer patients...
Nonpharmacologic and complementary approaches to cancer pain managementLynette A Menefee
Jefferson Medical College, Department of Anesthsiology, Jefferson Pain Center, 834 Chestnut St, Philadelphia, PA 19107 5127, USA
J Am Osteopath Assoc 105:S15-20. 2005..It focuses on those modalities that have empirical support or promising preliminary evidence, with the goal of familiarizing physicians with treatment modalities that may complement regular oncologic care...
Complementary and alternative medicine therapies in mood disordersAleeze S Moss
Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
Expert Rev Neurother 11:1049-56. 2011..There is an increasing number of research studies on CAM intervention in mood disorders, and this article critiques such data and attempts to provide a clinical perspective within which these CAM interventions might be considered...
Positron emission tomography in psychiatric disordersAndrew B Newberg
Department of Emergency Medicine and Radiology, Thomas Jefferson University, 1015 Chestnut Street, Suite 412, Philadelphia, PA 19107, USA
Ann N Y Acad Sci 1228:E13-25. 2011....
Practical geriatrics: depression, cognition, and anxiety among postmenopausal women with breast cancerDaniel A Monti
Jefferson-Myrna Brind Center for Integrative Medicine at Thomas Jefferson University, 111 South 11th Street, Suite 6215, Gibbon Building, Philadelphia, Pennsylvania 19107, USA
Psychiatr Serv 56:1353-5. 2005
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancerDaniel A Monti
Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America
PLoS ONE 7:e29794. 2012..Preclinical data support further investigation of ascorbic acid in pancreatic cancer. There are currently insufficient safety data in human subjects, particularly when ascorbic acid is combined with chemotherapy...
